Statin use and survival in CLL/SLL treated with ibrutinib: pooled analysis of 4 randomized controlled trials

Abstract: Patients with chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) have seen significant treatment advancements with the emergence of Bruton tyrosine kinase inhibitors like ibrutinib. Statin use has been linked to reduced mortality in several cancers, including CLL. Howe...

Cijeli opis

Bibliografski detalji

Glavni autori:	Ahmad Y. Abuhelwa, Sara A. Almansour, Jennifer R. Brown, Humaid O. Al-Shamsi, Ziad Abuhelwa, Zelal Kharaba, Yasser Bustanji, Mohammad H. Semreen, Salma Ali, Ahmad Alhuraiji, Ross A. McKinnon, Michael J. Sorich, Karem H. Alzoubi, Ashley M. Hopkins
Format:	Artigo
Jezik:	Inglês
Izdano:	Elsevier 2025-07-01
Serija:	Blood Advances
Online pristup:	http://www.sciencedirect.com/science/article/pii/S2473952925002435
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!